CHU Sanou Souro, Bobo-Dioulasso Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2006
NCT00122538
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier Universitaire Souro, Bobo Dioulasso, Burkina Faso. | Day Hospital, CHU Sanou Souro, Bobo Dioulasso, Burkina Faso | University Hospital Souro Sanou, Burkina Faso | University Hospital Sourô Sanou of Bobo Dioulasso (Burkina Faso)